These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. Nicholls SJ; Hsu A; Wolski K; Hu B; Bayturan O; Lavoie A; Uno K; Tuzcu EM; Nissen SE J Am Coll Cardiol; 2010 May; 55(21):2399-407. PubMed ID: 20488313 [TBL] [Abstract][Full Text] [Related]
7. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin. Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234 [TBL] [Abstract][Full Text] [Related]
8. Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study. Nicholls SJ; Tuzcu EM; Wolski K; Bayturan O; Lavoie A; Uno K; Kupfer S; Perez A; Nesto R; Nissen SE J Am Coll Cardiol; 2011 Jan; 57(2):153-9. PubMed ID: 21211686 [TBL] [Abstract][Full Text] [Related]
9. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS. Puri R; Nissen SE; Menon V; Shao M; Hsu A; Bakris GL; Kastelein JJ; Williams B; Armbrecht J; Brunel P; Kataoka Y; Nicholls SJ Atherosclerosis; 2015 Dec; 243(2):553-9. PubMed ID: 26523993 [TBL] [Abstract][Full Text] [Related]
10. Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN. Stegman B; Shao M; Nicholls SJ; Elshazly M; Cho L; King P; Kapadia S; Tuzcu M; Nissen SE; Puri R Atherosclerosis; 2016 Nov; 254():78-84. PubMed ID: 27710808 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study. Endo H; Dohi T; Miyauchi K; Kuramitsu S; Kato Y; Okai I; Yokoyama M; Yokoyama T; Ando K; Okazaki S; Shimada K; Suwa S; Daida H J Cardiol; 2019 Aug; 74(2):102-108. PubMed ID: 30737184 [TBL] [Abstract][Full Text] [Related]
18. Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN). Nicholls SJ; Borgman M; Nissen SE; Raichlen JS; Ballantyne C; Barter P; Chapman MJ; Erbel R; Libby P Curr Med Res Opin; 2011 Jun; 27(6):1119-29. PubMed ID: 21446892 [TBL] [Abstract][Full Text] [Related]
19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620 [TBL] [Abstract][Full Text] [Related]
20. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]